XyloCor Therapeutics

HQ
King of Prussia
17 Total Employees
Year Founded: 2013
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

XyloCor Therapeutics Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
HQKing of Prussia, Pennsylvania, USA